Men who experienced a heart attack or stroke allegedly due to their use of AndroGel or another “Low T” prescription therapy treatment may be eligible to file a testosterone lawsuit. The attorneys at Bernstein Liebhard LLP are actively evaluating cases on behalf of individuals whose stroke or heart attack followed use of a prescription testosterone therapy treatment. AndroGel lawsuit filings allege injuries caused by a class of medications designed to raise levels of the hormone in conjunction with another medical condition.

Individuals who have already filed cases over “Low T” treatments seek compensation for out-of-pocket medical expenses, lost wages, pain and suffering and other damages that may have been incurred by their situation.

On January 31, 2014, the U.S. Food and Drug Administration (FDA) issued a Drug Safety Communication involving AndroGel and other testosterone-raising medications. The public health alert vowed to conduct a safety review of the following prescriptions:

  • AndroGel
  • Androderm
  • Axiron
  • Bio-T-Gel
  • Delatestryl
  • Depo-Testosterone
  • Fortesta
  • Striant
  • Testopel

If you are a man who took one of the above “Low T” treatments, call our Firm for a free and confidential evaluation of your case. Our attorneys are standing by to answer any questions you may have regarding the legal process of filing a testosterone lawsuit, and will help you understand how to best protect your legal rights.

What is a “Low T” Testosterone Treatment?

“Low T” testosterone treatments are designed to raise the hormone in men who may be suffering from abnormally-low levels, also known as hypogonadism. In the U.S. Food and Drug Administration (FDA)’s approval of medications like AndroGel, the agency has specifically stated that they should only be given to men suffering from low levels of testosterone caused by certain genetic conditions, chemotherapy side effects, problems with the hypothalamus or pituitary glands, or another health issue.

A number of AndroGel lawsuit filings, however, allege that this is not always the case, and its manufacturer may have marketed the medication to men with normal levels of the hormone. A New York Times report from February 2014 goes on to say that “Low T” manufacturers have promoted these medications “as a cure-all for low energy, low libido, depression and other ills among middle-aged men.”

According to the February 4th article in the Times, the use of Low T therapies quadrupled in men over 40 between 2001 and 2011. One in 25 men over the age of 60 is currently undergoing testosterone therapy, the report also noted.

The FDA’s Drug Safety Communication in January was not the first time AndroGel has been scrutinized. In 1997, its manufacturer was taken to task by the FDA for the drug’s promotion for uses that may include “the treatment of geriatric hypogonadism in elderly men.” The FDA issued another warning letter in 2000 that flagged certain marketing claims as misleading. AndroGel was only approved for “primary” testicular problems and secondary problems like pituitary or hypothalamus disorders, according to the FDA letter.

AndroGel Lawsuit Filings Follow FDA Alert

Following the FDA’s notification in January 2014 about certain “Low T” treatment therapies, a number of AndroGel lawsuit claims were filed in the U.S. District Court, Northern District of Illinois. Court documents indicate that four cases were filed with the Court on February 4th by men who similarly allege that its manufacturer promoted the prescription therapies to treat low libido, fatigue and other symptoms normally associated with aging.

Preceding the FDA’s public health alert, two studies found an increase in serious cardiovascular events associated with “Low” treatments. In November 2013, research published in the Journal of the American Medical System showed older men with pre-existing heart problems to be at an increased risk for strokes, heart attacks and death, while a study published in January reported a doubled heart attack risk in younger men with pre-existing heart conditions, and all men over the age of 65.

Filing a Testosterone Lawsuit

Individuals who may have suffered a testosterone stroke or heart attack may be eligible to file an AndroGel lawsuit, or a claim involving a similar medication. Claims involving testosterone treatments seek compensation for lost wages, medical bills, pain and suffering, emotional distress and other problems that may have resulted in wrongful death. Call our Firm today at (877) 779-1414.

Published February 25, 2014 by